Industry – Page 2

Pharma’s wins and losses in Trump’s sprawling executive order on drug prices

2 months ago talkbio0Tagged drug price, Industry, Insulin, IRA, losses, Mediation, Medicare, Prices, small molecule drugs

Medicare, Medicare, Industry, drug price, Mediation, small molecule drugs, losses, IRA, Insulin, Prices

Biopharma Layoff Trends in Q1 2025 and Outlook for Q2

2 months ago talkbio0Tagged Biopharma, Biopharma layoffs, Changing, Industry, Legal patent, Pharma, pharmaceutical employment, Q1 2025, Q2 layoff, regulatory, restructuring

Biopharma layoffs, Q1 2025 layoffs, biotech job cuts, pharma workforce reductions, restructuring, patent cliffs, regulatory challenges, Q2 layoff forecast, pharmaceutical employment trends, biopharma industry changes.

Biotech and Pharma Job Cuts: Opthea and Pfizer Restructure Amid Industry Challenges

2 months ago talkbio0Tagged biotech, Clinical Trial Failures, Cost savings programs, Glycogen storage disease type II, Industry, Opthea layoffs, Pfizer, Pfizer staff, Pharma, restructuring

Opthea layoffs 2025 , Pfizer staff reduction , Biotech job cuts , Pharma restructuring , Clinical trial failures , Wet AMD treatment , Cost savings programs , Pfizer San Diego layoffs , Biotech industry challenges

The 5 Largest Biopharma Layoffs of Q1 2025: An Overview of Industry Restructuring

2 months ago talkbio0Tagged 2025, Biopharma layoffs, Drug Industry, Galapagos layoffs, Gilead, Industry, losses, Merck, Myers, Novartis, Q1 2025, restructuring, Squibb Layoffs, trends qualifier

Biopharma layoffs 2025, Novartis layoffs, Galapagos layoffs, Bristol Myers Squibb layoffs, Merck cuts, Gilead workforce reduction, Q1 2025 job cuts, biotech restructuring, pharmaceutical industry job losses, industry trends.

GLP-1 Injectables Will Soon Be Joined by Orals. Is the Industry Ready to Scale?

2 months ago talkbio0Tagged Effectiveness, GLP-1s, Glucagon-Like Peptide 1, Industry, Injectables, Manufacture, Market, Oral cavity, Orals, orforglipron, production

Glucagon-Like Peptide 1, Industry, Market, Effectiveness, Oral cavity, production, injectables, Orals, orforglipron, Manufacture, GLP-1s

Drugmakers renew concerns over UK’s attractiveness for investment

3 months ago talkbio0Tagged attractiveness, concerns, Industry, Investments, UK, UK 's

Investments, UK, UK ‘s, concerns, Industry, attractiveness

Lonza’s Vision for the Future: A Fireside Chat with New CEO Wolfgang Wienand

3 months ago talkbio0Tagged Biological Factors, CDMO, Cells, gene therapy, Industry, Leadership, Lonza, pharmaceutical manufacturing, Small Molecule, Wolfgang Wienand

Lonza, Wolfgang Wienand, CDMO, Pharmaceutical manufacturing, Biologics, Cell and gene therapy, Small molecules, Leadership transition, Industry outlook